A Study To Compare The Effects Of The Infusion Of A Sepsis Drug Between Healthy Adults And Adults With Damaged Livers
Status:
Completed
Trial end date:
2005-10-26
Target enrollment:
Participant gender:
Summary
This compound, GR270773, is a lipid based compound being developed to treat Sepsis. Lipids
are broken down in the body by the liver. This study is designed to see whether the effect of
the drug in people with poorly functioning livers is any different to the effect on healthy
adults.